JP2008133274A5 - - Google Patents

Download PDF

Info

Publication number
JP2008133274A5
JP2008133274A5 JP2007284586A JP2007284586A JP2008133274A5 JP 2008133274 A5 JP2008133274 A5 JP 2008133274A5 JP 2007284586 A JP2007284586 A JP 2007284586A JP 2007284586 A JP2007284586 A JP 2007284586A JP 2008133274 A5 JP2008133274 A5 JP 2008133274A5
Authority
JP
Japan
Prior art keywords
nrr
compound according
independently
aryl
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007284586A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008133274A (ja
JP4937881B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2008133274A publication Critical patent/JP2008133274A/ja
Publication of JP2008133274A5 publication Critical patent/JP2008133274A5/ja
Application granted granted Critical
Publication of JP4937881B2 publication Critical patent/JP4937881B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2007284586A 2006-11-01 2007-10-31 アズレン化合物 Expired - Fee Related JP4937881B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85578106P 2006-11-01 2006-11-01
US60/855,781 2006-11-01

Publications (3)

Publication Number Publication Date
JP2008133274A JP2008133274A (ja) 2008-06-12
JP2008133274A5 true JP2008133274A5 (cg-RX-API-DMAC7.html) 2012-03-01
JP4937881B2 JP4937881B2 (ja) 2012-05-23

Family

ID=39079326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007284586A Expired - Fee Related JP4937881B2 (ja) 2006-11-01 2007-10-31 アズレン化合物

Country Status (4)

Country Link
US (1) US7714146B2 (cg-RX-API-DMAC7.html)
EP (1) EP1918277B1 (cg-RX-API-DMAC7.html)
JP (1) JP4937881B2 (cg-RX-API-DMAC7.html)
TW (1) TWI350169B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2328876B1 (en) * 2008-09-02 2012-11-21 Actimis Pharmaceuticals, Inc., Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
US8492374B2 (en) * 2009-04-29 2013-07-23 Industrial Technology Research Institute Azaazulene compounds
CA2768948A1 (en) * 2009-07-28 2011-02-03 Nippon Zoki Pharmaceutical Co., Ltd. Process for producing thiabenzoazulene-propionic acid derivative
US9156827B2 (en) 2010-04-30 2015-10-13 The University Of Tokyo Anticancer agent
CN110041186A (zh) * 2018-01-15 2019-07-23 中国海洋大学 愈创木薁醛二缩合体的制备与应用
CN115745729B (zh) * 2022-12-09 2025-09-05 中国海洋大学 一种愈创木薁的茋类衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9611797D0 (en) * 1996-06-06 1996-08-07 Pharmacia Spa Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
EP1066257A2 (en) * 1998-03-26 2001-01-10 Sugen, Inc. Heterocylic classes of compounds for the modulating tyrosine protein kinase
AR035721A1 (es) * 2000-12-20 2004-07-07 Sugen Inc Indolinonas 4-aril sustituidas; sus composiciones farmaceuticas y metodo para modular la actividad catalitica de una proteina quinasa
US20050049267A1 (en) 2002-03-01 2005-03-03 Pintex Pharmaceuticals, Inc. Pin1-modulating compounds and methods of use thereof
US20040186160A1 (en) * 2002-12-13 2004-09-23 Sugen, Inc. Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2012505871A5 (cg-RX-API-DMAC7.html)
JP2008133274A5 (cg-RX-API-DMAC7.html)
JP2010511721A5 (cg-RX-API-DMAC7.html)
RU2442778C2 (ru) Новые соединения, действующие как ингибиторы erk
JP2009536221A5 (cg-RX-API-DMAC7.html)
JP2012515776A5 (cg-RX-API-DMAC7.html)
JP2011522789A5 (cg-RX-API-DMAC7.html)
JP2014528466A5 (cg-RX-API-DMAC7.html)
JP2007511504A5 (cg-RX-API-DMAC7.html)
CA2569850A1 (en) 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido [2,3-d] pyrimidine derivatives and related compounds for the treatment of cancer
JP2014528467A5 (cg-RX-API-DMAC7.html)
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
JP2006502143A5 (cg-RX-API-DMAC7.html)
JP2008525416A5 (cg-RX-API-DMAC7.html)
JP2004131511A5 (cg-RX-API-DMAC7.html)
JP2010506854A5 (cg-RX-API-DMAC7.html)
JP2009504772A5 (cg-RX-API-DMAC7.html)
JP2011509309A5 (cg-RX-API-DMAC7.html)
JP2011519360A5 (cg-RX-API-DMAC7.html)
JP2014524441A5 (cg-RX-API-DMAC7.html)
JP2015522650A5 (cg-RX-API-DMAC7.html)
RU2012123154A (ru) Способы лечения синдрома фибромиалгии
NO20080738L (no) Fremgangsmater for neurobeskyttelse
RU2012155118A (ru) Способы лечения биполярного расстройства
JP2007513998A5 (cg-RX-API-DMAC7.html)